Cangene has pretty much only other treatment for smallpox. Their vaccinia immunoglobulin. They are bought out at a $3.44. Closing price was $2.70 yesterday. Not much of a premium. I'm sure EBS would love to have ST 246 in its arsenal as well. If I was shareholder in Cangene I wouldn't be happy with the sale price though.